About the Company
- Date of Establishment
- Feb. 22, 1984
- Chang Young-kil
- 93.0 billion won (as of the end of 2015)
- No. of Executives & Employees
- 247 (as of 2015)
- Parent Company
- Hanmi Pharm Co., Ltd.
The 21st century leader in life sciences focusing on human respect and value creation
Hanmi Fine Chemical, founded in 1984, has emerged as a world-class supplier of active pharmaceutical ingredients through ceaseless R&D efforts and facility investment based on the management philosophy emphasizing the importance of human respect and value creation. For the past 30 years, we have pioneered and led the active pharmaceutical ingredient manufacturing industry, exporting technologies to multinational pharmaceutical companies and expanding into the European and US markets with our outstanding technology, quality control system and infrastructure.
Our company is characterized by our longstanding corporate culture and the dedication of its executives and employees, who are committed to the production of superior pharmaceutical ingredients and fulfillment of our social responsibility. With efforts to engage in mutual growth with our employees and contribute to society, we will continue to promote the health of mankind as the world’s leading fine chemical company that sets the bar in domestic and overseas markets.
Top Products and Facilities
Hanmi Fine Chemical is equipped with the top cGMP facilities and products among the domestic manufacturers of active pharmaceutical ingredients (APIs).
Our products such as cephalosporin-based antibiotics and general pharmaceuticals are well-known for their superior quality, and our technological prowess has been recognized in the domestic market as well as the markets of advanced countries such as the United States, United Kingdom, Germany and Japan. On a particular note, we became the first Korean pharmaceutical manufacturer to expand into the US market in 2006 after receiving approval of the sterile APIs through a field inspection by the US FDA.
Also, in 2007, we completed the construction of the API synthesis plant with the world’s top facilities and scale and diversified the demonstrated our product lineup with a focus on the cepha-based products, thereby demonstrating our standing as one of the top API manufacturers. The new plant has been certified for its conformance with the requirements for cGMP manufacturing facilities by FDA (US), BSG (Germany), TGA (Australia) and PMDA (Japan). As a current supplier of APIs to a number of multinational pharmaceutical companies in some 40 countries around the world, we are indisputably the top API manufacturer in terms of annual and accumulated export figures.
Dedicated Top Professionals
Hanmi Fine Chemical operates an R&D center with top researchers. We have made notable achievements through our ceaseless R&D efforts and investment into our facilities. Our products, nearly all of which are manufactured with our proprietary technology, are of the highest quality that meets the the global standards. Such achievements have been made possible with the use of advanced equipment and production facilities, the innovative R&D efforts of the top professionals, and the special know-hows accumulated with years of experience. Sparing no efforts toward R&D projects, we have secured a research team comprised of researchers with Master’s and Doctorate degrees that account for 16% of all our employees as of 2012 and devoted our resources to support and fund the R&D projects. In the recent years, we have established a new projects division to develop new materials and substances aside from developing active pharmaceutical ingredients, collaborated with other research institutes including ones affiliated with universities, and introduced the open lab system to enhance our competency and growth potential.
Top Quality Control
With diverse advanced equipment, top professionals and systematic operation, Hanmi Fine Chemical implements a quality control and assurance system that conforms to the cGMP regulations throughout all the processes from receiving raw materials to shipping the finished products. Superior quality products have been manufactured and managed with the introduction of a strict evaluation system for the manufacturing environment including water, equipment and facilities, implementation of manufacturing processes that have been scientifically and systematically validated, utilization of testing equipment that is maintained at its top functioning capacity, and recruitment of top professionals. The excellence of the quality control and assurance system of Hanmi Fine Medical has been proven, passing more than 100 audits performed by multinational companies and government agencies of advanced countries in Europe and the United States. With commitment to quality assurance, we will continue to dedicate our efforts to gain more trust in our products and management methods.